ArriVent BioPharma Q3 EPS $(0.81) Beats $(1.05) Estimate, Sales $5.000M
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Beats
ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.05) by 22.86 percent. This is a 2.41 percent increase over losses of $(0.83) per share
ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.05) by 22.86 percent. This is a 2.41 percent increase over losses of $(0.83) per share from the same period last year. The company reported $5.000 million in sales this quarter.